Surzebiclimab Biosimilar - Research Grade

Human

HAVCR2ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q8TDQ0

Blue ice

TIM-3 (HAVCR2) is an inhibitory checkpoint receptor on exhausted T cells and other immune cells, drawing strong interest in cancer immunology. The reagent here is a research-grade, unconjugated analog of surzebiclimab, a recombinant anti-TIM-3 monoclonal antibody intended for research use only. It is produced to in vivo standards with low endotoxin and offered in scalable milligram to gram quantities to support high-throughput programs. It is used in checkpoint-blockade functional assays, in vitro T-cell exhaustion screens, and in vivo immune-modulation models. Uniform, reproducible material supports robust experimental design at research scale. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks